News

Marta Miączyńska, Director of the International Institute of Molecular and Cell Biology in Warsaw (IIMCB), and Anders H. Lund, Director of the Biotech Research & Innovation Centre (BRIC) at the University of Copenhagen.

Marta Miączyńska (IIMCB) and Anders H. Lund (BRIC) appointed new Chair and Co-Chair of EU-LIFE

08/1/2026

Marta Miączyńska, Director of the International Institute of Molecular and Cell Biology in Warsaw (IIMCB), and Anders H. Lund, Director of the Biotech Research & Innovation Centre (BRIC) at the University of Copenhagen, have been appointed the new Chair and Co-Chair of EU-LIFE.

Ageing Cell Conference. A conference report

01/1/2017

EU-LIFE Science Newsletter 3/2017 Community News from the Babraham Institute (BI), United Kingdom The Babraham Institute’s ‘Ageing Cell’ conference...

The life cycle of proteins

01/1/2017

EU-LIFE Science Newsletter 3/2017 News from the Max Delbrück Center for Molecular Medicine (MDC), Germany Some proteins behave in an unusual way: the...

Making sense of drug combinations with mathematical models

01/1/2017

EU-LIFE Science Newsletter 3/2017 News from the Institute for Molecular Medicine Finland (FIMM), Finland Combinatorial therapies can tackle the drug...

Open Science policy @ EU-LIFE

01/1/2017

EU-LIFE Science Newsletter 3/2017 Latest News from EU-LIFE Moving forward with FAIR data, the European Science Cloud, the future of scientific...

Molecular mechanism controlling fat accumulation elucidated

01/1/2017

EU-LIFE Science Newsletter 3/2017 News from the Friedrich Miescher Institute for Biomedical Research (FMI), Switzerland Scientists in Rafal Ciosk’s...

World’s first Academic Extracellular Vesicle Core Facility

01/1/2017

EU-LIFE Science Newsletter 3/2017 Community News from the Institute for Molecular Medicine Finland (FIMM), Finland The recently established EV Core at...

CrispRGold: Online tool streamlines genome editing

01/1/2017

EU-LIFE Science Newsletter 3/2017 Community News from the Max Delbrück Center for Molecular Medicine (MDC), Germany For the CRISPR-Cas9 system to work...